Suparat Kanjanavanit
AuthID: R-00K-VZZ
1
TITLE: Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically- suppressed children and adolescents living with HIV-Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trial
AUTHORS: Compagnucci, Alexandra; Chan, Man K.; Saidi, Yacine; Cressey, Tim R.; Bamford, Alasdair; Riault, Yoann; Coelho, Alexandra; Nolan, Aoife; Chalermpantmetagul, Suwalai; Morkunaite, Gabija; Amuge, Pauline; Musiime, Victor; Violari, Avy; Cotton, Mark; Kekitiinwa, Adeodata R.; Kaudha, Elizabeth; Groenewald, Marisa; Liberty, Afaaf A.; Kanjanavanit, Suparat; Volokha, Alla; ...More
PUBLISHED: 2023, SOURCE: ECLINICALMEDICINE, VOLUME: 60
AUTHORS: Compagnucci, Alexandra; Chan, Man K.; Saidi, Yacine; Cressey, Tim R.; Bamford, Alasdair; Riault, Yoann; Coelho, Alexandra; Nolan, Aoife; Chalermpantmetagul, Suwalai; Morkunaite, Gabija; Amuge, Pauline; Musiime, Victor; Violari, Avy; Cotton, Mark; Kekitiinwa, Adeodata R.; Kaudha, Elizabeth; Groenewald, Marisa; Liberty, Afaaf A.; Kanjanavanit, Suparat; Volokha, Alla; ...More
PUBLISHED: 2023, SOURCE: ECLINICALMEDICINE, VOLUME: 60
INDEXED IN: 
Scopus 
WOS
Scopus WOS